TIMP2 and endometrial cancer: Overexpression of miR-200b in adenocarcinoma cells has also been found to inhibit the expression of the tissue inhibitor of metalloproteinase-2 (TIMP2), and increase the matrix metalloproteinase level (MMP), revealing the implication of miR-200b in endometrial cancer metastasis (216).